Inventor · disambiguated record
Kerry W. Fowler
Also filed as: FOWLER KERRY W
43 granted patents·9 pending applications·1,156 citations·filing 1985–2020
98Inventor score
Top patents by PatentIndex Score
52 records- 0198US8980901B25-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 17, 2015·39 cites·21 claims
- 0298USRE44599EQuinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 12, 2013·44 cites·6 claims
- 0398US7932260B2Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2005·Granted Apr 26, 2011·221 cites·2 claims
- 0497US8779131B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Jul 15, 2014·30 cites·10 claims
- 0597US8586597B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 19, 2013·36 cites·6 claims
- 0697US8207153B2Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaFOWLER KERRY W·Filed 2010·Granted Jun 26, 2012·51 cites·6 claims
- 0796US8993583B25-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 31, 2015·22 cites·13 claims
- 0896USRE44638EQuinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaFOWLER KERRY W·Filed 2005·Granted Dec 10, 2013·46 cites·2 claims
- 0995US9149477B25-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2014·Granted Oct 6, 2015·17 cites·12 claims
- 1094US6423710B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Jul 23, 2002·47 cites·27 claims
- 1194US4704382APhenylpiperazine phosphonatesSEARLE & CO·Filed 1986·Granted Nov 3, 1987·44 cites·19 claims
- 1293US6348602B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Feb 19, 2002·49 cites·33 claims
- 1391US10336756B2(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2015·Granted Jul 2, 2019·5 cites·2 claims
- 1491US6486186B2Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the sameICOS CORP·Filed 2001·Granted Nov 26, 2002·43 cites·5 claims
- 1590US9884876B2Anti-viral compounds, pharmaceutical compositions, and methods of use thereofKINETA INC·Filed 2015·Granted Feb 6, 2018·21 cites·14 claims
- 1690US6372777B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Apr 16, 2002·36 cites·26 claims
- 1790US5401880AChemical prevention or reversal of cataract by phase separation inhibitorsOCULON CORP·Filed 1992·Granted Mar 28, 1995·33 cites·16 claims
- 1889US6458787B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Oct 1, 2002·24 cites·22 claims
- 1988US6258833B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 1999·Granted Jul 10, 2001·55 cites·37 claims
- 2087US6680336B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2002·Granted Jan 20, 2004·23 cites·4 claims
- 2186US6294561B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Sep 25, 2001·22 cites·37 claims
- 2285US6569890B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2002·Granted May 27, 2003·19 cites·28 claims
- 2385US6500856B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Dec 31, 2002·20 cites·4 claims
- 2485US6313156B1Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Nov 6, 2001·20 cites·35 claims
- 2584US6716871B2Cyclic AMP-specific phosphodie sterase inhibitorsICOS CORP·Filed 2002·Granted Apr 6, 2004·14 cites·5 claims
- 2684US6569885B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted May 27, 2003·18 cites·13 claims
- 2784US6455562B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Sep 24, 2002·18 cites·5 claims
- 2884US6376489B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Apr 23, 2002·22 cites·45 claims
- 2984US5098915ASubstituted N-benzylpiperidine amidesSEARLE & CO·Filed 1989·Granted Mar 24, 1992·20 cites·139 claims
- 3084US5028616AN-benzylpiperidine amidesSEARLE & CO·Filed 1989·Granted Jul 2, 1991·18 cites·15 claims
- 3182US9073946B2Anti-viral compoundsKINETA INC·Filed 2013·Granted Jul 7, 2015·3 cites·10 claims
- 3282US6924284B2PARP inhibitorsDELTAGEN RES LABS LLC·Filed 2002·Granted Aug 2, 2005·42 cites·55 claims
- 3378US10906907B2Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereofICOS CORP·Filed 2019·Granted Feb 2, 2021·0 cites·9 claims
- 3477US2021332047A1Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2020·Application pending·0 cites
- 3568US5247119APhenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressivesSEARLE & CO·Filed 1992·Granted Sep 21, 1993·10 cites·10 claims
- 3668US4628095ASubstituted N-benzyl-4-(benzhydryl) piperidinesSEARLE & CO·Filed 1985·Granted Dec 9, 1986·13 cites·7 claims
- 3766US6998416B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2004·Granted Feb 14, 2006·1 cites·2 claims
- 3861US2012015964A1Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaFOWLER KERRY W·Filed 2011·Application pending·0 cites
- 3960US7176229B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2005·Granted Feb 13, 2007·0 cites·7 claims
- 4055US2020270274A1Anti-viral compounds, pharmaceutical compositions, and methods of use thereofKINETA INC·Filed 2020·Application pending·0 cites
- 4153US7087634B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2003·Granted Aug 8, 2006·0 cites·20 claims
- 4253US2016122312A1Anti-viral compounds, pharmaceutical compositions and methods of use thereofKINETA INC·Filed 2014·Application pending·0 cites
- 4351US5070094AN-benzyltropaneamidesSEARLE & CO·Filed 1989·Granted Dec 3, 1991·5 cites·13 claims
- 4450US9956285B2Anti-viral compoundsKINETA INC·Filed 2017·Granted May 1, 2018·0 cites·6 claims
- 4549US2019002477A1Anti-viral compounds, pharmaceutical compositions, and methods of use thereofKINETA INC·Filed 2018·Application pending·0 cites
- 4648US9555106B2Anti-viral compoundsKINETA INC·Filed 2012·Granted Jan 31, 2017·0 cites·8 claims
- 4748US4680295AOctahydropyrido[1,2-c]pyrimidinones and hexahydropyrido[1,2-c]pyrimidinedionesSEARLE & CO·Filed 1986·Granted Jul 14, 1987·4 cites·27 claims
- 4848US2015342932A1Anti-viral compoundsKINETA INC·Filed 2015·Application pending·0 cites
- 4946US2014227321A1Anti-viral compoundsKINETA INC·Filed 2012·Application pending·0 cites
- 5041US2007259863A1Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide DerivativesICOS CORP·Filed 2005·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kerry W. Fowler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →